Breaking News, Collaborations & Alliances

LakePharma, Harbour Antibodies Form Discovery Partnership

Agreement provides access to H2L2 platform use with LakePharma's discovery and develop-ment services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

LakePharma, U.S.-based contract research organization (CRO) specializing in antibody and pro-tein engineering, cell line development, and protein production, and Harbour Antibodies BV, a Harbour BioMed subsidiary, have formed a technology partnership. The partnership provides LakePharma the right to utilize Harbour Antibodies’ patented H2L2 transgenic mouse platform in its therapeutic antibody discovery service offerings to clients in pharmaceutical and thera-peutic biotechnology companies...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters